Contact Thomas

Speaking Engagements

  

Strategies for Targeting Kinases
Paid

There has been growing interest in targeting kinases such as JAK, TYK, IRAK, SIK, CDK, MEK, ERK, RTK, PLK, PI3K, ALK, MAPK, GSK, LRRK, and more for their role in neurodegeneration, inflammation, cancer, autoimmune, and other disorders. However, targeting kinases selectively and specifically has always been a challenge, as they intersect so many pat

25-25 September 2023
Healthcare
  

Protein Degraders and Molecular Glues – Part 1
Paid

A new generation of molecules are being developed to disrupt protein-protein interactions and to hijack the cell’s natural machinery for targeted protein degradation. Proteolysis-targeting chimeras (PROTACs), molecular glues, and other modalities are utilizing the ubiquitin-proteasome, lysosome, and autophagy systems to seek out previously “undrugg

26-27 September 2023
Healthcare